Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-08-014674
Filing Date
2008-03-12
Accepted
2008-03-12 12:05:43
Documents
1
Period of Report
2008-03-11

Document Format Files

Seq Description Document Type Size
1 v106667_ex.html 4  
1 v106667_ex.xml 4 2901
  Complete submission text file 0001144204-08-014674.txt   4725
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

EIN.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address 177 POST STREET SUITE 900 SAN FRANCISCO CA 94108
Business Address 415-677-9677
Masterson Nola E (Reporting) CIK: 0001305231 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 08682856